However, cardiomyocyte-specific transgenic OE of active HDAC6 with αMHC promoter exacerbated atrial fibrillation and interstitial fibrosis (Sawa et al., 2021), suggesting a role of HDAC6 catalytic activity in atrial fibrillation. Here, HDAC6 is linked to atrial fibrillation.